Kulke MH - Search Results

1

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.

Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG, Ellis LM, Benedetti JK, Bergsland EK, Hobday TJ, Van Cutsem E, Pingpank J, Oberg K, Cohen SJ, Posner MC, Yao JC. Kulke MH, et al. J Clin Oncol. 2011 Mar 1;29(7):934-43. doi: 10.1200/JCO.2010.33.2056. Epub 2011 Jan 24. J Clin Oncol. 2011. PMID: 21263089 Free PMC article.

2

Recent developments in the pharmacological treatment of advanced pancreatic cancer.

Kulke MH. Kulke MH. Expert Opin Investig Drugs. 2003 Jun;12(6):983-92. doi: 10.1517/13543784.12.6.983. Expert Opin Investig Drugs. 2003. PMID: 12783602 Review.

3

Neuroendocrine tumours: clinical presentation and management of localized disease.

Kulke MH. Kulke MH. Cancer Treat Rev. 2003 Oct;29(5):363-70. doi: 10.1016/s0305-7372(03)00072-0. Cancer Treat Rev. 2003. PMID: 12972355 Review.

4

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. Cancer. 2004 Sep 1;101(5):934-9. doi: 10.1002/cncr.20466. Cancer. 2004. PMID: 15329900 Free article. Clinical Trial.

5

Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.

McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS. McCollum AD, et al. Among authors: kulke mh. Am J Clin Oncol. 2004 Oct;27(5):485-8. doi: 10.1097/01.coc.0000135343.06038.eb. Am J Clin Oncol. 2004. PMID: 15596916

6

Advances in the treatment of neuroendocrine tumors.

Kulke M. Kulke M. Curr Treat Options Oncol. 2005 Sep;6(5):397-409. doi: 10.1007/s11864-005-0043-9. Curr Treat Options Oncol. 2005. PMID: 16107243 Review.

7

Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS. Ogino S, et al. Among authors: kulke mh. Clin Cancer Res. 2005 Sep 15;11(18):6650-6. doi: 10.1158/1078-0432.CCR-05-0738. Clin Cancer Res. 2005. PMID: 16166444 Clinical Trial.

8

Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.

Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, Winer EP, Enzinger PC, Bunnell CA, Kulke MH, Fuchs CS. Meyerhardt JA, et al. Among authors: kulke mh. J Clin Oncol. 2005 Nov 20;23(33):8453-60. doi: 10.1200/JCO.2005.02.5460. J Clin Oncol. 2005. PMID: 16293876

9

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.

Kulke MH, Stuart K, Enzinger PC, Ryan DP, Clark JW, Muzikansky A, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. J Clin Oncol. 2006 Jan 20;24(3):401-6. doi: 10.1200/JCO.2005.03.6046. J Clin Oncol. 2006. PMID: 16421420 Clinical Trial.

10

The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.

McCollum AD, Wu B, Clark JW, Kulke MH, Enzinger PC, Ryan DP, Earle CC, Michelini A, Fuchs CS. McCollum AD, et al. Among authors: kulke mh. Am J Clin Oncol. 2006 Feb;29(1):40-4. doi: 10.1097/01.coc.0000190456.83788.51. Am J Clin Oncol. 2006. PMID: 16462501 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters